BioStem Technologies, Inc. (BSEM) AI Dilution Summary

BioStem is funding itself from cash of $6,962,492 at 2026-06-30 against estimated monthly burn of $1,833,333, alongside a $40,000,000 committed equity line with Roth Principal Investments, LLC. Its most recent raise was a private placement that closed 2026-09-30 for $3,000,000 gross: 735,296 shares at $4.08, with H.C. Wainwright & Co., LLC as placement agent. Dilution here is driven mainly by that equity line, which is price-linked.